CIK 0001382574 · Non-accelerated filer<br>Smaller reporting company
Scienture Holdings, Inc.
Sign in to watch- Ticker
- SCNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 261 0281
- Business address
- 20 AUSTIN BLVD., COMMACK, NY, 11725
- Former names
- TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC., Bluebird Exploration Co.
- 4 Open-market sale Director sold 7,407 shares at an average $0.56 ($4,176)
- 4 Open-market sale Director sold 800 shares at $5.30 ($4,240)
- 4 Open-market sale President sold 7,500 shares at $5.29 ($39,703)
- 4 Open-market sale Director sold 500 shares at $5.30 ($2,650)
- 4 Open-market sale Director sold 1,800 shares at $5.26 ($9,460)
- 4 Open-market sale President sold 7,500 shares at an average $5.46 ($40,935)
- 4 Other disposition CEO disposed of 201,613 shares (other)
- 4 Grant or award President acquired 50,000 shares (grant or award)
- 4 Grant or award CEO acquired 123,504 shares (grant or award)
- 4 Grant or award Director acquired 8,987 shares (grant or award)
- 4 Grant or award Director acquired 8,987 shares (grant or award)
- 4 Grant or award Director acquired 8,987 shares (grant or award)
- 4 Grant or award CFO acquired 12,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 4 · 75 filings